News Archive

Clinical phase completion of phase I trial with MAD0004J08 monoclonal antibody against SARS-CoV-2

Dec 20, 2021

December 2021 – CROss Alliance® is glad to announce the …

Read more

GIQAR 2021 – The effect of Covid-19 pandemic on Quality

Nov 11, 2021

October 2021 – CROss Alliance QA Unit attended the XXIX …

Read more

CROss Alliance® successful outcome of Swissmedic GCP System Inspection

Jul 27, 2021

July 2021 – As required by Federal Laws, CROSS activities …

Read more

Accelera and CROSS: an integrated solution for Pre-clinical to Clinical transition

May 17, 2021

May 2021 – The relationship between Accelera and CROss Alliance®…

Read more

CROSS Research participation in phase 1 study with monoclonal antibody against SARS-COV2

Mar 9, 2021

March 2021 – CROss Alliance® is excited to share …

Read more

Participation of CROss Alliance® in the Zurich Life Science Day 2021

Feb 11, 2021

February 2021 – On the 4th of February, Ursula …

Read more

Covid-19 – Phase I unit re-open

Jun 23, 2020

June 2020 – We are relieved to announce that CROSS …

Read more

Covid-19 – CROss Alliance® measures

Apr 2, 2020

2nd April 2020 – Almost one month has passed …

Read more

Covid-19 – CROss Alliance® update

Mar 9, 2020

March 2020 – CROss Alliance® would like to inform its …

Read more

Merger by incorporation of CROSS Metrics SA in CROSS Research SA

Jan 10, 2020

January 2020 – CROss Alliance® would like to announce …

Read more